Effect of etanercept on iritis in patients with ankylosing spondylitis
Open Access
- 4 November 2004
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (11) , 3736-3737
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trialArthritis & Rheumatism, 2003
- Long‐term outcome of etanercept therapy in children with treatment‐refractory uveitisArthritis & Rheumatism, 2003
- Does etanercept induce uveitis?British Journal of Ophthalmology, 2003
- Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitisArthritis & Rheumatism, 2003
- Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by MethotrexateArchives of Ophthalmology (1950), 2003
- Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor α inhibitorsAnnals of the Rheumatic Diseases, 2003
- Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic diseaseArthritis & Rheumatism, 2001
- Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trialThe Lancet, 2000